LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Home・Listă Acțiuni・Becton Dickinson and Co

Becton Dickinson and Co

Închisă

Sector Sănătate

240.13 -0.62

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

239.14

Maxim

242.59

Indicatori cheie
By Trading Economics
Venit	-50M 487M
Vânzări	10M 5.1B
P/E Medie Sector	50.04 112.16
EPS	3.5
Marjă de profit	9.625
EBITDA	-124M 1.2B

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+17.31 upside

Dividende
By Dow Jones
Următoarele câștiguri	7 nov. 2024
Data viitoare de dividende	27 dec. 2024
Următoarea dată ex-dividende	5 dec. 2024

Statistici piață
By TradingEconomics
Capitalizare de piață	-150M 69B
Deschiderea anterioară	240.75
Închiderea anterioară	240.13

Sentimentul știrilor

By Acuity

46%

54%

162 / 366 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bullish Evidence

235.4 / 242.08 Suport & Rezistență

Becton Dickinson and Co Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

1 aug. 2024, 11:08 UTC

Câștiguri

Becton 3Q Adjusted Earnings Top Views But International Sales Weigh on FY24 Outlook

3 iun. 2024, 11:18 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash

2 mai 2024, 11:07 UTC

Câștiguri

Becton Dickinson Shakes Up 2024 Outlook After Growing 2Q Sales, Earnings

1 aug. 2024, 10:37 UTC

Câștiguri

Becton Dickinson Now Sees FY24 Revenue About $20.1B; Had Seen $20.1B-$20.3B >BDX

1 aug. 2024, 10:35 UTC

Câștiguri

Becton Dickinson Sees FY24 Revenue Up About 3.7%, Organic Revenue Up 5%-5.25% >BDX

1 aug. 2024, 10:35 UTC

Câștiguri

Becton Dickinson Sees FY24 Adj EPS $13.05-Adj EPS $13.15 >BDX

1 aug. 2024, 10:30 UTC

Câștiguri

Becton Dickinson 3Q EPS $1.68 >BDX

1 aug. 2024, 10:30 UTC

Câștiguri

Becton Dickinson 3Q Net $487M >BDX

1 aug. 2024, 10:30 UTC

Câștiguri

Becton Dickinson 3Q Adj EPS $3.50 >BDX

1 aug. 2024, 10:30 UTC

Câștiguri

Becton Dickinson 3Q Rev $5B >BDX

4 iun. 2024, 17:26 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3 iun. 2024, 15:30 UTC

Acțiuni populare

Stocks to Watch Monday: GameStop, AMC, Paramount, Nvidia -- WSJ

3 iun. 2024, 13:26 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3 iun. 2024, 12:25 UTC

Top știri

Achiziții, Fuziuni, Preluări

Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- Update

3 iun. 2024, 11:03 UTC

Top știri

Achiziții, Fuziuni, Preluări

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash

3 iun. 2024, 10:40 UTC

Achiziții, Fuziuni, Preluări

Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch

3 iun. 2024, 10:32 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson: Acquired Business Has About 4,500 Employees >BDX EW

3 iun. 2024, 10:31 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson: Acquired Business Generated More Than $900 Million Revenue in 2023 >BDX

3 iun. 2024, 10:31 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson: Deal Expands Portfolio of Smart Connected Care Solutions >BDX EW

3 iun. 2024, 10:30 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson to Buy Edwards Lifesciences Critical Care Product Group for $4.2 Billion >BDX EW

3 iun. 2024, 10:30 UTC

Achiziții, Fuziuni, Preluări

BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW

2 mai 2024, 10:35 UTC

Câștiguri

Becton Dickinson Had Seen FY24 Adjusted EPS $12.82-$13.06 >BDX

2 mai 2024, 10:34 UTC

Câștiguri

Becton Dickinson Raises FY24 View To Adj EPS $12.95-Adj EPS $13.15 >BDX

2 mai 2024, 10:34 UTC

Câștiguri

Becton Dickinson Still Sees FY24 Organic Revenue Growth of 5.5%-6.25% >BDX

2 mai 2024, 10:33 UTC

Câștiguri

Becton Dickinson Had Seen FY24 Revenue $20.2B-$20.4B >BDX

2 mai 2024, 10:33 UTC

Câștiguri

Becton Dickinson Cuts FY24 View To Rev $20.1B-$20.3B >BDX

2 mai 2024, 10:30 UTC

Câștiguri

Becton Dickinson 2Q Net $537M >BDX

2 mai 2024, 10:30 UTC

Câștiguri

Becton Dickinson 2Q Adj EPS $3.17 >BDX

2 mai 2024, 10:30 UTC

Câștiguri

Becton Dickinson 2Q EPS $1.85 >BDX

2 mai 2024, 10:30 UTC

Câștiguri

Becton Dickinson 2Q Rev $5B >BDX

Comparație

Modificare preț

Becton Dickinson and Co Așteptări

Obiectiv de preț

By TipRanks

17.31% sus

Prognoză pe 12 luni

Medie 281.83 USD 17.31%

Maxim 312 USD

Minim 260 USD

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruBecton Dickinson and Co - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

12 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 12 analiști care au acordat evaluări ale acțiunilor Becton Dickinson and Co - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

235.4 / 242.08Suport & Rezistență

Recent bullish events outweigh bearish events.

The bullish and bearish events are balanced.

Sentiment

By Acuity

162 / 366 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Becton Dickinson and Co

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.